Improving access to therapeutic innovation

Natividad Calvente Cestafe, Director of Innovation, Training and Institutional Relations at the General Council of Pharmaceutical Associations contributes to a monographic issue of the journal Cuadernos de Derecho Farmacéutico [Pharmaceutical Law Review] with a magnificent article on early access to therapeutic innovation, which is one of the greatest challenges faced by health systems and the pharmaceutical industry in recent years.

Using a multidisciplinary approach, it addresses the need to tackle this challenge, which must be faced by regulators, funders, the pharmaceutical industry and, above all, the patients who need improved health outcomes and better quality of care.

It also analyses the current difficulties in accessing innovative medicinal products and reviews the initiatives currently under way to make improvements.

Access 

This post is also available in: Spanish